Breaking News Instant updates and real-time market news.

AZN

AstraZeneca

$33.92

-0.1 (-0.29%)

15:10
05/19/17
05/19
15:10
05/19/17
15:10

AstraZeneca attracts a large call spread

AstraZeneca attracts a large call spread. The stock off a dime to $33.92 and 15K Sep 30 - 35 call spreads sold at $2.90. The activity is possibly closing or, more likely, rolling a bullish position to out of the money Sep 35s from in the money Sep 30s. Trade history shows notable buying of Sep 30 calls early this year when 20K were bought for $1.45 on 1/20/17. The stock was near $27 at the time.

  • 19

    May

  • 26

    Jun

AZN AstraZeneca
$33.92

-0.1 (-0.29%)

05/17/17
JPMS
05/17/17
UPGRADE
Target $72
JPMS
Overweight
Clovis upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Cory Kasimov upgraded Clovis Oncology (CLVS) to Overweight and raised his price target for the shares to $72 from $58. The stock closed yesterday up 2%, or $1.05, to $49.56. The shares are down 35% over the last two months for "no clear fundamental reason," Kasimov tells investors in a research note. The analyst is "increasingly comfortable" recommending Clovis ahead of its Phase 3 study evaluating Rubraca in maintenance ovarian cancer now that more PARP class data has emerged. He has not seen "convincing evidence" that there is a clear efficacy difference between Clovis' rucaparib, Tesaro's (TSRO) niraparib and AstraZeneca's (AZN) olaparib.
05/16/17
LEER
05/16/17
NO CHANGE
Target $36
LEER
Outperform
AstraZeneca price target raised to $36 from $33 at Leerink
Leerink analyst Seamus Fernandez raised his price target for AstraZeneca to $36 after hosting a call with a lung cancer specialist. The specialist believes that once approved, the uptake of AstraZeneca's Imfinzi in Stage III unresectable non-small cell lung cancer will be "significant" given the poor outcomes and general lack of an effective treatment standard in this setting, Fernandez tells investors in a research note. The analyst raised his peak worldwide forecasts for the drug by $1B and keeps an Outperform rating on AstraZeneca.
05/15/17
LEER
05/15/17
NO CHANGE
LEER
GlaxoSmithKline possible move to buyout Novartis stake makes sense, says Leerink
Leerink analyst Seamus Fernandez is not surprised by the news that GlaxoSmithKline (GSK) may buyout Novartis' (NVS) 36.5% stake in its Consumer Healthcare joint venture through a GBP8B deal sooner rather than later. The analyst believes this buyout could be beneficial as the infusion of additional cash from the buyout could bolster Novartis appetite for large scale M&A, including companies such as AstraZeneca (AZN) whose immune-oncology assets could complement its small-molecule focused oncology portfolio, according to the London Times.
05/12/17
05/12/17
UPGRADE

Neutral
AstraZeneca upgraded to Neutral at Credit Suisse
As previously reported, Credit Suisse analyst Rebekah Harper upgraded AstraZeneca to Neutral from Underperform after the company reported surprise positive headline results from the Phase 3 PACIFIC trial for Imfinzi in stage 3 unresectable lung cancer in all-comers, with positive progression free survival data. The analyst believes that AstraZeneca is in a "unique position" with this indication, with a likely two to three years lead versus competitors, as other P3s are not due until 2020+. Harper expects U.S. approval for AstraZeneca in this indication before the end of 2017.

TODAY'S FREE FLY STORIES

AMZN

Amazon.com

$1,025.67

-3.03 (-0.29%)

, WFM

Whole Foods

$41.71

-0.05 (-0.12%)

06:35
07/24/17
07/24
06:35
07/24/17
06:35
Periodicals
Democrats in Congress urge review of Amazon's Whole Foods deal, Reuters says »

A group of Democrats in…

AMZN

Amazon.com

$1,025.67

-3.03 (-0.29%)

WFM

Whole Foods

$41.71

-0.05 (-0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

PPG

PPG

$106.37

-0.35 (-0.33%)

06:33
07/24/17
07/24
06:33
07/24/17
06:33
Downgrade
PPG rating change  »

PPG downgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXAS

Abraxas Petroleum

$1.61

-0.04 (-2.42%)

06:33
07/24/17
07/24
06:33
07/24/17
06:33
Initiation
Abraxas Petroleum initiated  »

Abraxas Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

CALM

Cal-Maine Foods

$37.10

1 (2.77%)

06:33
07/24/17
07/24
06:33
07/24/17
06:33
Earnings
Cal-Maine Foods reports Q4 EPS (51c) with items, consensus (25c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jul

SGMS

Scientific Games

06:33
07/24/17
07/24
06:33
07/24/17
06:33
Earnings
Scientific Games reports Q2 EPS (44c), consensus (52c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

HAS

Hasbro

$115.95

1.05 (0.91%)

06:33
07/24/17
07/24
06:33
07/24/17
06:33
Hot Stocks
Hasbro CEO says entered 2H with 'strong consumer momentum' »

"The Hasbro team…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 03

    Aug

HAS

Hasbro

$115.95

1.05 (0.91%)

06:31
07/24/17
07/24
06:31
07/24/17
06:31
Hot Stocks
Hasbro CFO says seeing 'some softness' in Brazil, U.K. »

"Our balance sheet…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 03

    Aug

ALRN

Aileron Therapeutics

$12.78

-0.14 (-1.08%)

06:31
07/24/17
07/24
06:31
07/24/17
06:31
Initiation
Aileron Therapeutics initiated  »

Aileron Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPRX

Catalyst Pharmaceuticals

$2.95

-0.1 (-3.28%)

06:30
07/24/17
07/24
06:30
07/24/17
06:30
Conference/Events
Catalyst Pharmaceuticals management to meet with Piper Jaffray »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

HAS

Hasbro

$115.95

1.05 (0.91%)

06:30
07/24/17
07/24
06:30
07/24/17
06:30
Earnings
Hasbro reports Q2 EPS 53c, consensus 46c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 03

    Aug

VLO

Valero

$67.78

0.26 (0.39%)

, PSX

Phillips 66

$82.85

0.49 (0.59%)

06:28
07/24/17
07/24
06:28
07/24/17
06:28
Periodicals
U.S. mulls financial sanctions on Venezuela's PDVSA, Reuters reports »

The Trump administration…

VLO

Valero

$67.78

0.26 (0.39%)

PSX

Phillips 66

$82.85

0.49 (0.59%)

CVX

Chevron

$103.25

-1.38 (-1.32%)

PBF

PBF Energy

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 28

    Jul

  • 01

    Aug

  • 03

    Aug

KCDMY

Kimberly-Clark de Mexico

$10.34

-0.3 (-2.82%)

06:28
07/24/17
07/24
06:28
07/24/17
06:28
Upgrade
Kimberly-Clark de Mexico rating change  »

Kimberly-Clark de Mexico…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PPG

PPG

$106.37

-0.35 (-0.33%)

06:28
07/24/17
07/24
06:28
07/24/17
06:28
Downgrade
PPG rating change  »

PPG downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FND

Floor & Decor

$37.40

-1.1 (-2.86%)

06:28
07/24/17
07/24
06:28
07/24/17
06:28
Upgrade
Floor & Decor rating change  »

Floor & Decor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

BABA

Alibaba

$151.89

-0.22 (-0.14%)

, MGI

MoneyGram

$16.56

-0.28 (-1.66%)

06:26
07/24/17
07/24
06:26
07/24/17
06:26
Periodicals
Smith says U.S. should block Ant, MoneyGram deal, NY Post reports »

Rep. Chris Smith, the…

BABA

Alibaba

$151.89

-0.22 (-0.14%)

MGI

MoneyGram

$16.56

-0.28 (-1.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRSN

Mersana Therapeutics

$14.05

-0.14 (-0.99%)

06:25
07/24/17
07/24
06:25
07/24/17
06:25
Initiation
Mersana Therapeutics initiated  »

Mersana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTZ

MasTec

$45.30

-0.35 (-0.77%)

06:25
07/24/17
07/24
06:25
07/24/17
06:25
Upgrade
MasTec rating change  »

MasTec upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Aug

WFC

Wells Fargo

$54.17

-0.71 (-1.29%)

06:23
07/24/17
07/24
06:23
07/24/17
06:23
Hot Stocks
Wells Fargo ordered to reinstate whistleblower, pay $577K in back wages, damages »

The U.S. Department of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

  • 15

    Jan

MIK

Michaels

$19.02

0.22 (1.17%)

06:23
07/24/17
07/24
06:23
07/24/17
06:23
Upgrade
Michaels rating change  »

Michaels upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRSN

Mersana Therapeutics

$14.05

-0.14 (-0.99%)

06:21
07/24/17
07/24
06:21
07/24/17
06:21
Initiation
Mersana Therapeutics initiated  »

Mersana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$66.00

-0.36 (-0.54%)

06:21
07/24/17
07/24
06:21
07/24/17
06:21
Conference/Events
Citi to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

SFTBF

SoftBank

$82.90

-0.25 (-0.30%)

06:20
07/24/17
07/24
06:20
07/24/17
06:20
Periodicals
Didi Chuxing, SoftBank to invest $2B in ride-hail startup Grab, Recode says »

Chinese ride-hailing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHF

Brighthouse Financial

, MET

MetLife

$54.65

0.07 (0.13%)

06:20
07/24/17
07/24
06:20
07/24/17
06:20
Initiation
Brighthouse Financial, MetLife initiated  »

Brighthouse Financial…

BHF

Brighthouse Financial

MET

MetLife

$54.65

0.07 (0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 14

    Aug

  • 15

    Aug

ACM

Aecom

$32.02

-0.25 (-0.77%)

06:19
07/24/17
07/24
06:19
07/24/17
06:19
Downgrade
Aecom rating change  »

Aecom downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

TEVA

Teva

$32.64

0.21 (0.65%)

06:18
07/24/17
07/24
06:18
07/24/17
06:18
Periodicals
Teva to cut Israeli workforce, mainly in production, Reuters reports »

Teva is planning to cut…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 30

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.